Study of the Feasibility of Early Lung Ultrasound in Neonatal Respiratory Distress in Premature Newborns Born Between 32 Weeks of Amenorrhea and 36 Weeks Plus 6 Days of Amenorrhea, Hospitalized in the Neonatal Pediatrics and Intensive Care Units of the Dijon University Hospital
NCT ID: NCT05737095
Last Updated: 2025-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
69 participants
OBSERVATIONAL
2022-11-27
2024-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective is to evaluate the feasibility of performing a pulmonary ultrasound within 6 hours after admission in premature infants born between 32 weeks of amenorrhea and 36 weeks of amenorrhea + 6 days who are hospitalized for initial respiratory distress.
Pulmonary ultrasound is performed within 6 hours of admission and an ultrasound score is calculated according to the images observed.
Continued management according to protocols without taking into account the ultrasound data.
Follow-up of patients until discharge from hospital or D28 of life (whichever comes first)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lung Ultrasound as a Predictor of Mechanical Ventilation in Neonates Older Than 32 Weeks
NCT02449863
Point of Care Lung Ultrasound in Preterm Infants with Respiratory Distress
NCT05925075
Interest of Pulmonary Ultrasound to Predict Evolution Towards Bronchopulmonary Dysplasia in Premature Infants at Gestational Age Less Than or Equal to 34 Weeks of Gestation
NCT04209088
Ultrasound for Assessment of Extubation Readiness
NCT04957264
Lung Ultrasound for Prediction of Bronchopulmonary Dysplasia
NCT04756297
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Premature infants
premature infants born between 32 and 36 weeks of amenorrhea + 6 days hospitalized for respiratory distress
Pulmonary ultrasound
Within 6 hours of admission to Neonatal Pediatrics and Intensive Care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pulmonary ultrasound
Within 6 hours of admission to Neonatal Pediatrics and Intensive Care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Premature infant (between 32 weeks of amenorrhea and 36 weeks of amenorrhea + 6 days) admitted for neonatal respiratory distress that began in the first 2 hours of life
* Hospitalized at the Dijon University Hospital in the Neonatal Pediatrics and Intensive Care Units
Exclusion Criteria
* major intrathoracic or abdominal malformation
0 Hours
2 Hours
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Dijon Bourgogne
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TERNOY-LANZINI 2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.